|
ANKRD52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.313800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.945600E-02 |
| Normal-vs-Stage2 |
3.024400E-01 |
| Normal-vs-Stage3 |
6.838200E-01 |
| Normal-vs-Stage4 |
2.538200E-01 |
| Stage1-vs-Stage2 |
7.974600E-01 |
| Stage1-vs-Stage3 |
1.846190E-01 |
| Stage1-vs-Stage4 |
8.186200E-02 |
| Stage2-vs-Stage3 |
2.359400E-01 |
| Stage2-vs-Stage4 |
1.154210E-01 |
| Stage3-vs-Stage4 |
3.862200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.375900E-02 |
| Normal-vs-AfricanAmerican |
1.018390E-01 |
| Normal-vs-Asian |
4.155200E-01 |
| Caucasian-vs-AfricanAmerican |
7.456800E-01 |
| Caucasian-vs-Asian |
2.514000E-01 |
| AfricanAmerican-vs-Asian |
1.842960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.132400E-02 |
| Normal-vs-Female |
4.834400E-02 |
| Male-vs-Female |
5.766400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.546800E-01 |
| Normal-vs-Extreme_Weight |
9.327600E-01 |
| Normal-vs-Obese |
1.196960E-01 |
| Normal-vs-Extreme_Obese |
4.204200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.302200E-01 |
| Normal_Weight-vs-Obese |
1.364380E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.674800E-01 |
| Extreme_Weight-vs-Obese |
1.815210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.352800E-01 |
| Obese-vs-Extreme_Obese |
7.681000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.473150E-01 |
| Normal-vs-Age(41-60Yrs) |
5.783700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.942800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.087000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.344400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.357000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.116400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.988500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.697700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.993560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.208300E-04 |
| Normal-VS-Type2 PRCC |
9.881900E-02 |
| Normal-VS-KIRP CIMP |
3.290400E-01 |
| Normal-VS-Unclassified PRCC |
1.083880E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.18909999999606E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.451600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.225400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.252200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.221580E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.965700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.219400E-01 |
| Normal-vs-N1 |
9.475200E-01 |
| Normal-vs-N2 |
2.891400E-01 |
| N0-vs-N1 |
7.182000E-01 |
| N0-vs-N2 |
5.011400E-01 |
| N1-vs-N2 |
7.043200E-01 |
|
|
